Literature DB >> 19217753

Substance abuse, coping strategies, adaptive skills and behavioral and emotional problems in clients with mild to borderline intellectual disability admitted to a treatment facility: a pilot study.

Robert Didden1, Petri Embregts, Mirjam van der Toorn, Nina Laarhoven.   

Abstract

Many clients with mild to borderline intellectual disability (ID) who are admitted to a treatment facility show serious problems in alcohol and/or drugs use. In the present case file study, we explored differences in coping strategies, adaptive skills and emotional and behavioral problems between clients who showed substance abuse and clients who did not. There were no differences in adaptive skills between groups. However, compared to clients without substance abuse, those who abused substances showed a more palliative coping style, and had more severe emotional and behavior problems such as anxiety/depression and intrusive thoughts and aggressive and antisocial behaviors. Implications for treatment are discussed.

Entities:  

Mesh:

Year:  2009        PMID: 19217753     DOI: 10.1016/j.ridd.2009.01.002

Source DB:  PubMed          Journal:  Res Dev Disabil        ISSN: 0891-4222


  11 in total

Review 1.  Substance abuse among individuals with intellectual disabilities.

Authors:  Shawna L Carroll Chapman; Li-Tzy Wu
Journal:  Res Dev Disabil       Date:  2012-03-07

2.  A Systematic Review of Substance Use (Disorder) in Individuals with Mild to Borderline Intellectual Disability.

Authors:  Neomi van Duijvenbode; Joanne E L VanDerNagel
Journal:  Eur Addict Res       Date:  2019-07-22       Impact factor: 3.015

3.  Evaluating a personalized treatment for substance use disorder in people with mild intellectual disability or borderline intellectual functioning: A study protocol of a multiple baseline across individuals design.

Authors:  Lotte C F Gosens; Roy Otten; Robert Didden; Evelien A P Poelen
Journal:  Contemp Clin Trials Commun       Date:  2020-07-16

4.  Extended brief intervention to address alcohol misuse in people with mild to moderate intellectual disabilities living in the community (EBI-ID): study protocol for a randomised controlled trial.

Authors:  Christos Kouimtsidis; Lucy Fodor-Wynne; Katrina Scior; Rachael Hunter; Gianluca Baio; Vittoria Pezzoni; Angela Hassiotis
Journal:  Trials       Date:  2015-03-25       Impact factor: 2.279

5.  Relationship of Coping Styles with Suicidal Behavior in Hospitalized Asthma and Chronic Obstructive Pulmonary Disease Patients: Substance Abusers versus Non- Substance Abusers.

Authors:  Mitra Safa; Fatemeh Ghassem Boroujerdi; Firouzeh Talischi; Mohammad Reza Masjedi
Journal:  Tanaffos       Date:  2014

6.  Effectiveness of a mindfulness-oriented substance use prevention program for boys with mild to borderline intellectual disabilities: study protocol for a randomised controlled trial.

Authors:  Lucie Waedel; Anne Daubmann; Antonia Zapf; Olaf Reis
Journal:  BMC Public Health       Date:  2020-11-25       Impact factor: 3.295

7.  Music Therapy Interventions for Stress Reduction in Adults With Mild Intellectual Disabilities: Perspectives From Clinical Practice.

Authors:  Martina de Witte; Esther Lindelauf; Xavier Moonen; Geert-Jan Stams; Susan van Hooren
Journal:  Front Psychol       Date:  2020-12-10

8.  Intellectual disability among Dutch homeless people: prevalence and related psychosocial problems.

Authors:  Barbara Van Straaten; Carola T M Schrijvers; Jorien Van der Laan; Sandra N Boersma; Gerda Rodenburg; Judith R L M Wolf; Dike Van de Mheen
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

9.  The Relationship of Early Maladaptive Schemas, Attributional Styles and Learned Helplessness among Addicted and Non-Addicted Men.

Authors:  Farhad Shaghaghy; Majid Saffarinia; Mohadeseh Iranpoor; Ali Soltanynejad
Journal:  Addict Health       Date:  2011 Winter-Spring

10.  It is time to bring borderline intellectual functioning back into the main fold of classification systems.

Authors:  Jannelien Wieland; Frans G Zitman
Journal:  BJPsych Bull       Date:  2016-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.